-
Speaker
List
Print
-
All Conference Hall No.1（2F） Conference Hall No.5-A（1F） Conference Hall No.5-B（1F） Conference Hall No.5-C（1F） Conference Hall No.5-D（1F） Conference Hall No.2-A（2F） Conference Hall No.2-B（2F） Conference Hall No.2-C（2F） Conference Hall No.2-AB（2F） Conference Hall No.3（Vascular care）（1F） Convention Hall No.2（2F） Conference Hall 201-A（2F） Conference Room 201-AB（2F） Conference Room 201-ABC（2F） Conference Room 201-BC（2F） Conference Room 201-D（2F） Conference Room 201-CD（2F） Coference Room No.307（3F） Conference Room No.308（3F） Conference Hall No.2-VIP-room-A（2F） Electronic Poster Machine：Conference Hall No.4（1F） Satellite Symposium
| Date | Time | Hall | Session | Role | Title | Name |
| 2018-10-20 | 09:10-09:18 | Conference Room 201-AB（2F） | Venous disease---Bayer Healthcare Co. Ltd. | Symposium | Interpretation about the advances of anticoagulant treatment for VTE | Bi Jin |
| 2018-10-20 | 09:10-10:50 | Conference Room 201-AB（2F） | Venous disease---Bayer Healthcare Co. Ltd. | Moderator | Bi Jin | |
| 2018-10-20 | 10:50-12:20 | Conference Room 201-AB（2F） | Aortic arterial disease | Moderator | Bi Jin |
Announcement